Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells
Authors:
- Joanna S. KritikouJKJoanna S. Kritikou
- Mariana M.S. OliveiraMOMariana M.S. Oliveira
- Julien RecordJRJulien Record
- Mezida B. SaeedMSMezida B. Saeed
- Saket M. NigamSNSaket M. Nigam
- Minghui HeMHMinghui He
- Marton KeszeiMKMarton Keszei
- Arnika K. WagnerAWArnika K. Wagner
- Hanna BraunerHBHanna Brauner
- Anton SendelASAnton Sendel
- Saikiran K. SedimbiSSSaikiran K. Sedimbi
- Stamatina RentouliSRStamatina Rentouli
Open Access
- 22 March 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (6)
Abstract
X-linked neutropenia (XLN) is caused by gain-of-function mutations in the actin regulator Wiskott-Aldrich Syndrome protein (WASp). XLN patients have reduced numbers of cytotoxic cells in peripheral blood; however, their capacity to kill tumor cells remains to be determined. Here, we examined NK and T cells from 2 patients with XLN harboring the activating WASp L270P mutation. XLN patient NK and T cells had increased granzyme B content and elevated degranulation and IFN-γ production when compared with healthy control cells. Murine WASp L272P NK and T cells formed stable synapses with YAC-1 tumor cells and anti-CD3/CD28–coated beads, respectively. WASp L272P mouse T cells had normal degranulation and cytokine response whereas WASp L272P NK cells showed an enhanced response. Imaging experiments revealed that while WASp L272P CD8 + T cells had increased accumulation of actin upon TCR activation, WASp L272P NK cells had normal actin accumulation at lytic synapses triggered through NKp46 signaling but had impaired response to lymphocyte function associated antigen-1 engagement. When compared with WT mice, WASp L272P mice showed reduced growth of B16 melanoma and increased capacity to reject MHC class I–deficient cells. Together, our data suggest that cytotoxic cells with constitutively active WASp have an increased capacity to respond to and kill tumor cells.Keywords
This publication has 68 references indexed in Scilit:
- Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutationAnnals of Hematology, 2017
- A large kindred with X‐linked neutropenia with an I294T mutation of the Wiskott‐Aldrich syndrome geneBritish Journal of Haematology, 2008
- Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropeniaJournal of Experimental Medicine, 2007
- Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropeniaBlood, 2006
- Contingent Phosphorylation/Dephosphorylation Provides a Mechanism of Molecular Memory in WASPMolecular Cell, 2003
- Constitutively activating mutation in WASP causes X-linked severe congenital neutropeniaNature Genetics, 2001
- Mechanism of N-Wasp Activation by Cdc42 and Phosphatidylinositol 4,5-BisphosphateJournal of Cell Biology, 2000
- Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome proteinNature, 2000
- The Interaction between N-WASP and the Arp2/3 Complex Links Cdc42-Dependent Signals to Actin AssemblyCell, 1999
- Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndromeCurrent Biology, 1996